CLINICAL_TRIALS
trial_result
· 2018-10-19
Clinical Trial Update: A Pharmacokinetic Study of the Coadministration of LY2216684 With Sertraline [Phase 1]
Summary
Phase 1 pharmacokinetic study evaluating coadministration of LY2216684 with sertraline in adults with major depressive disorder.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Eli Lilly and Company | Conditions: Major Depressive Disorder | Phase 1 | Status: COMPLETED | Results posted: 2018-10-19